2-amino-6-methoxy-5-nitropyridine | 58819-89-9

• 分子结构分类: 有机化合物 - 有机1,3-偶极化合物 - 烯丙基型1,3-偶极有机化合物
• 英文名称: 2-amino-6-methoxy-5-nitropyridine
• 英文别名: 6-methoxy-5-nitropyridin-2-amine；6-methoxy-5-nitro-pyridin-2-ylamine；2-Amino-6-methox-5-nitroypyridine
• CAS: 58819-89-9
• 化学式: C₆H₇N₃O₃
• 分子量: 169.14
• InChiKey: ZLYBIYNRKMFNSF-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.6
• 重原子数：
  12
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  94
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  2-amino-6-methoxy-5-nitropyridine 在 sodium disulfite 作用下， 以 phosphate buffer 为溶剂， 反应 3.0h， 生成 3-amino-6-[[(diisopropylamino)methylene]amino]-2-methoxypyridine
  参考文献：
  名称：

  Certain 3,9-Dideazapurines as Inhibitors of Purine Nucleoside Phosphorylase

  摘要：

  The synthesis of four 3,9-dideazapurines is described. In order to achieve the desired substitution pattern, a new approach to the pyrrolo[2,3-c]pyridine ring system was devised utilizing the Gassman reaction as the key step for its construction. The four target heterocycles were all evaluated for their ability to inhibit human erythrocytic purine nucleoside phosphorylase.

  DOI：

  10.1080/07328319908044619
• 作为产物：
  描述：

  2-甲氧基-3-硝基吡啶 在 potassium permanganate 、 氨 作用下， 反应 5.0h， 以62%的产率得到2-amino-6-methoxy-5-nitropyridine
  参考文献：
  名称：

  Wozniak, Marian; Baranski, Andrzej; Szpakiewicz, Barbara, Liebigs Annalen der Chemie, 1991, # 9, p. 875 - 878

  摘要：

  DOI：

文献信息

• [EN] HETEROARYL DERIVATIVES OF FORMULA (I) AS ATF4 INHIBITORS<br/>[FR] DÉRIVÉS HÉTÉROARYLES DE FORMULE (I) UTILISÉS EN TANT QU'INHIBITEURS D'ATF4
  申请人：GLAXOSMITHKLINE IP DEV LTD

  公开号：WO2019193540A1

  公开（公告）日：2019-10-10

  The invention is directed to substituted heteroaryl derivatives. Specifically, the invention is directed to compounds according to Formula (I) wherein A, C, D, L2, L3, R1, R2, R3, R4, R 5, R6, z2, z4, z5, and z6 are as defined herein; or salts thereof. The compounds of the invention are inhibitors of the ATF4 pathway and can be useful in the treatment of cancer, pre-cancerous syndromes and diseases associated with activated unfolded protein response pathways, such as Alzheimer's disease, spinal cord injury, traumatic brain injury, ischemic stroke, stroke, diabetes, Parkinson disease, Huntington's disease, Creutzfeldt-Jakob Disease, and related prion diseases, progressive supranuclear palsy, amyotrophic lateral sclerosis, myocardial infarction, cardiovascular disease, inflammation, fibrosis, chronic and acute diseases of the liver, chronic and acute diseases of the lung, chronic and acute diseases of the kidney, chronic traumatic encephalopathy (CTE), neurodegeneration, dementia, cognitive impairment, atherosclerosis, ocular diseases, arrhythmias, in organ transplantation and in the transportation of organs for transplantation. Accordingly, the invention is further directed to pharmaceutical compositions comprising a compound of the invention. The invention is still further directed to methods of inhibiting the ATF4 pathway and treatment of disorders associated therewith using a compound of the invention or a pharmaceutical composition comprising a compound of the invention.

  该发明涉及取代杂环芳基衍生物。具体来说，该发明涉及符合以下式（I）的化合物，其中 A、C、D、L2、L3、R1、R2、R3、R4、R5、R6、z2、z4、z5 和 z6 如本文中所定义；或其盐。该发明的化合物是ATF4途径的抑制剂，可用于治疗癌症、癌前综合征以及与激活的未折叠蛋白反应途径相关的疾病，如阿尔茨海默病、脊髓损伤、创伤性脑损伤、缺血性中风、中风、糖尿病、帕金森病、亨廷顿病、克雅氏病、相关朊病、进行性核上性麻痹、肌萎缩侧索硬化、心肌梗死、心血管疾病、炎症、纤维化、肝脏慢性和急性疾病、肺部慢性和急性疾病、肾脏慢性和急性疾病、慢性创伤性脑病（CTE）、神经退行性疾病、痴呆、认知障碍、动脉粥样硬化、眼部疾病、心律失常、器官移植以及器官运输用于移植。因此，该发明还涉及包含该发明化合物的药物组合物。该发明还涉及使用该发明化合物或包含该发明化合物的药物组合物抑制ATF4途径和治疗相关疾病的方法。
• [EN] 6-HETEROARYLOXY BENZIMIDAZOLES AND AZABENZIMIDAZOLES AS JAK2 INHIBITORS<br/>[FR] 6-HÉTÉROARYLOXY BENZIMIDAZOLES ET AZABENZIMIDAZOLES UTILISÉS EN TANT QU'INHIBITEURS DE JAK2
  申请人：AJAX THERAPEUTICS INC

  公开号：WO2022140527A1

  公开（公告）日：2022-06-30

  The present disclosure provides 6-heteroaryloxy benzimidazole and azabenzimidazole compounds and compositions thereof useful for inhibiting JAK2.

  本公开提供6-杂环氧基苯并咪唑和氮杂苯并咪唑化合物及其组合物，用于抑制JAK2。
• MARTANI A.; FRAVOLINI A.; SCHIAFFELLA F.; ORZALESI G.; SELLERI R.; VOLPAT+, BOLL. CHIM. FARM. <BCFA-AT>, 1975, 114, NO 10, 590-597
  作者：MARTANI A.、 FRAVOLINI A.、 SCHIAFFELLA F.、 ORZALESI G.、 SELLERI R.、 VOLPAT+

  DOI：——

  日期：——
• Wozniak, Marian; Baranski, Andrzej; Szpakiewicz, Barbara, Liebigs Annalen der Chemie, 1991, # 9, p. 875 - 878
  作者：Wozniak, Marian、Baranski, Andrzej、Szpakiewicz, Barbara

  DOI：——

  日期：——
• Certain 3,9-Dideazapurines as Inhibitors of Purine Nucleoside Phosphorylase
  作者：Jerry D. Rose、John A. Secrist、John A. Montgomery

  DOI：10.1080/07328319908044619

  日期：1999.11

  The synthesis of four 3,9-dideazapurines is described. In order to achieve the desired substitution pattern, a new approach to the pyrrolo[2,3-c]pyridine ring system was devised utilizing the Gassman reaction as the key step for its construction. The four target heterocycles were all evaluated for their ability to inhibit human erythrocytic purine nucleoside phosphorylase.